Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Semacom Integrated Tbk. (SEMA)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Semacom Integrated Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Semacom Integrated Tbk. diperdagangkan di Rp146 (kapitalisasi pasar 177,84 M, volume 24 jam 83,16 jt). Perbedaan utamanya: Semacom Integrated Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SEMA | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 177,84 M |
Volume | — | 83,16 jt |
Lot | — | 831,61 rb |
Perputaran | — | 12,19 M |
Harga Rata-rata | — | 146,55 |
Nilai Transaksi | — | 12,19 M |
Harga Ekuilibrium Indikatif | — | 146 |
Volume Ekuilibrium Indikatif | — | 8,23 rb |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Semacom Integrated Tbk.
PT Semacom Integrated Tbk (the Company) was established in the Republic of Indonesia on October 01, 2009 based on Notarial deed No. 5 of H. Dana Sasmita, S.H, Notary in Jakarta The Company begin opertions commercial activities since 2009.
Selengkapnya di halaman SEMA →
